Early research (Phase 1)Study completedNCT00539383
What this trial is testing
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
Who this might be right for
Advanced Solid Tumors With and Without Brain Metastases
Angiochem Inc 56